Ethanol Vapours to Complement or Replace Sulfur Dioxide Fumigation of Table Grapes

Recent studies have shown that dipping table grapes in ethanol solutions at harvest improved storage of the fruit. We report here the first results obtained by treating "Chasselas" table grapes (Vitis vinifera) with ethanol vapours over the storage period. We tested the effect of ethanol at 0, 4 and 8 g/kg fruit during cold storage for 2, 4 and 6 weeks. We measured berry shatter, stem browning, Botrytis rot incidence and sensory appreciation by tasting panels. Ethanol vapours reduced Botrytis rot incidence and berry shatter, but hastened stem browning. Sensory analyses did not detect any differences between treatments

Common Reactions of Furfural to scalable processes of Residual Biomass

Energy and the environment will always play key roles in society. The climate emergency cannot be ruled out to enable the transition for a clean energy future. Currently, non-renewable energy resources are declining, therefore is important to continuously explore renewable resources. Biomass is a renewable resource that can be applied to reduce climate changes and to accomplhish emission policies. Cellulose is the most abundant type of biomass worldwide, which can be transformed into biofuels and potential building block platform molecules (e.g furfural) throughout biological or chemical methods. Furfural can be synthetized from cellulose using hydrolysis and dehydration reactions. Furfural has a furan ring and carbonyl functional group which makes it an important intermediary to produce higher value-added molecules at  industrial level. These molecules include gasoline, diesel and jet fuel. However, furfural can also be transformed by hydrogenation, oxidation, decarboxylation and condensation reactions. The selective hydrogenation of furfural produces furfuryl alcohol, an important industrial compound, which is widely employed in the production of resins, fibers, and is considered an essential product for pharmaceutical applications. On the other hand, the oxidation of furfural produces furoic acid which is appliedin the agrochemical industry, where it is commonly transformed to furoyl chloride which is finally  used in the production of drugs and insecticides. The oxidation and reduction of furfural can carry out through heterogeneous and homogeneous catalysis, and biocatalysis.  Selectivity is an important issue in furfural hydrogenation and oxidation reactions since different products can be obtained by using monometallic or bimetallic catalysts and/or different catalyst supports. In biocatalysis approach, different enzymes, complete cells, tools of modern biotechnology, DNA sequencing, regulation of metabolic networks, overexpression of genes that encode enzymes of interest and optimization of the cellular properties of the microorganism are used. Herein, a review on the current status of furfuryl alcohol and furoic acid production from furfural by heterogeneous catalysis and biocatalysis has been studied. The stability, selectivity and activity of catalystsalong with the different furfural oxidation and reduction conditions have been pointed out. Additionally, the main enzymes, microorganisms and mechanism involved in the furfural degradation process have also been discussed.publishersversionpublishe

Are patients ready for integrated person-centered care? A qualitative study of people with epilepsy in Ireland

The National Clinical Programme for Epilepsy (NCPE) in Ireland aims to deliver a holistic model of integrated person-centered care (PCC) that addresses the full spectrum of biomedical and psychosocial needs of people with epilepsy (PwE). However, like all strategic plans, the model encompasses an inherent set of assumptions about the readiness of the environment to implement and sustain the actions required to realize its goals. In this study, through the lens of PwE, the Irish epilepsy care setting was explored to understand its capacity to adopt a new paradigm of integrated PCC. Focus groups and semi-structured one-to-one interviews were employed to capture the qualitative experiences of a sample of Irish PwE (n = 27) in the context of the care that they receive. Participants were from different regions of the country and were aged between 18 and 55 years with 1 to 42 years since diagnosis (YSD). Highlighting a gap between policy intent and action on the ground, findings suggest that patient readiness to adopt a new model of care cannot be assumed. Expectations, preferences, behaviors, and values of PwE may sustain the more traditional constructions of healthcare delivery rather than the integrated PCC goals of reform. These culturally constituted perceptions illustrate that PwE do not instinctively appreciate the goals of healthcare reform nor the different behavior expected from them within a reformed healthcare system. Recalibrating deep-rooted patient views is necessary to accomplish the aspirations of integrated PCC. Patient engagement emphasizing the meaningful role that they can play in shaping their healthcare services is vital

Mitoxantrone and Analogues Bind and Stabilize i-Motif Forming DNA Sequences

YesThere are hundreds of ligands which can interact with G-quadruplex DNA, yet very few which target i-motif. To appreciate an understanding between the dynamics between these structures and how they can be affected by intervention with small molecule ligands, more i-motif binding compounds are required. Herein we describe how the drug mitoxantrone can bind, induce folding of and stabilise i-motif forming DNA sequences, even at physiological pH. Additionally, mitoxantrone was found to bind i-motif forming sequences preferentially over double helical DNA. We also describe the stabilisation properties of analogues of mitoxantrone. This offers a new family of ligands with potential for use in experiments into the structure and function of i-motif forming DNA sequences

Breast-specific gamma imaging as an adjunct modality for the diagnosis of invasive breast cancer with correlation to tumour size and grade

Objectives: The purpose of this study was to determine the sensitivity of breast-specific gamma imaging (BSGI) in the detection of invasive breast cancers and to characterise the sensitivity of BSGI based on tumour size and pathological grade. Methods: 139 females with invasive carcinoma who underwent BSGI were retrospectively reviewed. Patients were injected in the antecubital vein with 20-30 mCi (925-1110 MBq) of 99mTc-sestamibi. Images were obtained with a high-resolution, breast-specific gamma camera (Dilon 6800; Dilon Technologies, Newport News, VA) and were categorised based on radiotracer uptake as normal, normal with heterogeneous uptake, probably abnormal and abnormal. For a positive examination, the region of the area of increased uptake had to correlate with the laterality and location of the biopsy-proven cancer. Results: 149 invasive cancers in 139 patients with a mean size of 1.8cm (0.2-8.5 cm) were included. 146 were identified with BSGI (98.0%). All cancers which measured ≥0.7 cm (n=123) as well as all cancers grade 2 or higher (n=102), regardless of tumour size, were identified with BSGI (100%). There were 6 cancers that were pathological grade 1 and measured \u3c7 mm, of which 50% (3/6) were identified with BSGI. The overall sensitivity of BSGI for the detection of invasive breast cancer is 98.0%. The sensitivity for subcentimetre cancers is 88.5% (23/26). Conclusion: BSGI has a high sensitivity for the detection of invasive breast cancer. Our results demonstrate that BSGI detected all invasive breast cancers pathological grade 2 and higher regardless of size and all cancers which measured ≥7 mm regardless of grade. BSGI can reliably detect invasive breast cancers and is a useful adjunct imaging modality for the diagnosis of breast cancer. © 2012 The British Institute of Radiology

Breast-specific gamma imaging as an adjunct modality for the diagnosis of invasive breast cancer with correlation to tumour size and grade

Objectives: The purpose of this study was to determine the sensitivity of breast-specific gamma imaging (BSGI) in the detection of invasive breast cancers and to characterise the sensitivity of BSGI based on tumour size and pathological grade. Methods: 139 females with invasive carcinoma who underwent BSGI were retrospectively reviewed. Patients were injected in the antecubital vein with 20-30 mCi (925-1110 MBq) of 99mTc-sestamibi. Images were obtained with a high-resolution, breast-specific gamma camera (Dilon 6800; Dilon Technologies, Newport News, VA) and were categorised based on radiotracer uptake as normal, normal with heterogeneous uptake, probably abnormal and abnormal. For a positive examination, the region of the area of increased uptake had to correlate with the laterality and location of the biopsy-proven cancer. Results: 149 invasive cancers in 139 patients with a mean size of 1.8cm (0.2-8.5 cm) were included. 146 were identified with BSGI (98.0%). All cancers which measured ≥0.7 cm (n=123) as well as all cancers grade 2 or higher (n=102), regardless of tumour size, were identified with BSGI (100%). There were 6 cancers that were pathological grade 1 and measured \u3c7 mm, of which 50% (3/6) were identified with BSGI. The overall sensitivity of BSGI for the detection of invasive breast cancer is 98.0%. The sensitivity for subcentimetre cancers is 88.5% (23/26). Conclusion: BSGI has a high sensitivity for the detection of invasive breast cancer. Our results demonstrate that BSGI detected all invasive breast cancers pathological grade 2 and higher regardless of size and all cancers which measured ≥7 mm regardless of grade. BSGI can reliably detect invasive breast cancers and is a useful adjunct imaging modality for the diagnosis of breast cancer. © 2012 The British Institute of Radiology